ArticleAnnals of hematology2024
Tixagevimab/cilgavimab (AZD7442/Evusheld) prevent from COVID19 in patients with hematologic malignancies under active chemotherapy.
Yoo Jin Lee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it